Bristol Myers buys Nvidia chips for AI-powered drug discovery

Bristol Myers Squibb is purchasing new Nvidia chips to accelerate AI-driven drug discovery, according to CNBC's Jim Cramer's Monday market watchlist. Semiconductor stocks are broadly higher. Cramer highlights this as one of ten key things to watch in the stock market on Monday.